CIK 0001710340 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 80.0 M | 21.3 M | ||
| Net income (USD) | -9.0 M | -2.0 M | -28.0 M |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-14 | 8-K | FORM 8-K items 1.01,2.01,9.01 | 2026-10-14 |
| 2026-10-06 | 4 | FORM 4 | 2026-10-06 |
| 2026-10-06 | 144 | 144 | |
| 2026-09-28 | 8-K | FORM 8-K items 8.01,9.01 | 2026-09-28 |
| 2026-08-31 | 4/A | FORM 4/A | 2026-08-28 |
| 2026-08-28 | 4 | FORM 4 | 2026-08-28 |
| 2026-08-28 | 144 | 144 | |
| 2026-08-24 | 4 | FORM 4 | 2026-08-24 |
| 2026-08-24 | 144 | 144 | |
| 2026-08-20 | 4 | FORM 4 | 2026-08-19 |
| 2026-08-20 | 144/A | 144/A | |
| 2026-08-19 | 144 | 144 | |
| 2026-08-13 | 10-Q | FORM 10-Q | 2026-06-30 |
| 2026-08-13 | 8-K | FORM 8-K items 2.02,9.01 | 2026-08-13 |
| 2026-08-12 | 3 | PRIMARY DOCUMENT | 2026-07-31 |
| 2026-08-05 | 8-K | FORM 8-K items 1.01,2.01,9.01 | 2026-07-31 |
| 2026-08-04 | 4 | FORM 4 | 2026-07-31 |
| 2026-08-04 | 4 | FORM 4 | 2026-07-31 |
| 2026-08-04 | 4 | FORM 4 | 2026-07-31 |
| 2026-08-04 | 4 | FORM 4 | 2026-07-31 |
| 2026-08-04 | 4 | FORM 4 | 2026-07-31 |
| 2026-08-04 | 4 | FORM 4 | 2026-07-31 |
| 2026-08-04 | 4 | FORM 4 | 2026-07-31 |
| 2026-08-04 | 4 | FORM 4 | 2026-07-31 |
| 2026-08-04 | 8-K | FORM 8-K items 5.02 | 2026-07-31 |
Forms on file (last 1,000): 8-K 149, 4 112, 10-Q 24, 144 21, 3 15, SC 13G/A 9, DEF 14A 8, 10-K 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ETON (0.002 USD), /gw/filings/filings?ticker=ETON&form=8-K, /gw/filings/facts?ticker=ETON&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange